Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons
CONCLUSION: HR-CTV coverage was higher with IC/IS IGABT than with IC IGABT, with lower doses to the OAR in patients managed for LACC after RCT. Interstitial brachytherapy in the management of LACC after radiotherapy provides better coverage of the target volumes, this could contribute to better local control and improved survival of patients.PMID:38567146 | PMC:PMC10985138 | DOI:10.3389/fonc.2024.1347727
Source: Cancer Control - Category: Cancer & Oncology Authors: Abel Cordoba Estelle Gesta Alexandre Escande Alexandra Noeuveglise Romain Cayez Adrien Halty Mohamed Tahar Ladjimi Fabrice Narducci Delphine Hudry Carlos Martinez Gomez Sofia Cordoba Marie-C écile Le Deley Ma ël Barthoulot Eric F Lartigau Source Type: research
More News: Bladder Cancer | Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Colorectal Cancer | External Beam Therapy | Study